|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01093 CSPC PHARMA
Nominal 
7.650 +0.180 (+2.410%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 4,534,664 | 4,178,815 | 7,627,064 | 4,636,627 | 6,739,610 |
| Net Cash from / (used in) Investing Activities | (3,858,200) | 865,863 | (6,795,984) | (637,326) | (2,129,513) |
| Net Cash from / (used in) Financing Activities | (5,253,332) | (2,559,577) | (1,904,073) | (2,196,606) | (1,470,976) |
| Increase / (Decrease) in Cash & Cash Equivalents | (4,576,868) | 2,485,101 | (1,072,993) | 1,802,695 | 3,139,121 |
| Cash & Cash Equivalents at beginning of period | 10,490,845 | 8,000,852 | 9,059,709 | 7,259,458 | 4,118,236 |
| Effect of Foreign Exchange Rate Changes | 3,399 | 4,892 | 14,136 | (2,444) | 2,101 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 5,917,376 | 10,490,845 | 8,000,852 | 9,059,709 | 7,259,458 |
| Remarks: | Real time quote last updated: 31/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,547,851 |
| %Change | -15.645% |
| EPS / (LPS) | RMB 0.223 |
| NBV Per Share (¥) | RMB 2.887 |